Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic | Global Health | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic

Educational Objective
To understand how a potential shortage of hydroxychloroquine will affect patients with Lupus
1 Credit CME

The coronavirus disease 2019 (COVID-19) pandemic has created a global public health crisis and severe economic disruption. There are currently no effective therapies to prevent, treat, or cure COVID-19. To meet this need, the scientific community has mobilized to develop vaccines and drugs to prevent and treat COVID-19. Trials are underway to assess the effectiveness of existing drugs that hold promise in treating COVID-19. While the results of these trials are eagerly awaited, the US Food and Drug Administration recently authorized use of chloroquine and hydroxychloroquine for emergency treatment of COVID-19.

Sign in to take quiz and track your certificates

Buy This Activity
Article Information

Corresponding author: Bella Mehta, MBBS, MS, Hospital for Special Surgery, 535 E. 70th Street, New York, NY 10021 (drbellamehta@gmail.com).

Conflict of Interest Disclosures: None reported.

References
1.
Carter  EE , Barr  SG , Clarke  AE .  The global burden of SLE: prevalence, health disparities and socioeconomic impact.   Nat Rev Rheumatol. 2016;12(10):605-620. doi:10.1038/nrrheum.2016.137PubMedGoogle ScholarCrossref
2.
Ruiz-Irastorza  G , Ramos-Casals  M , Brito-Zeron  P , Khamashta  MA .  Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.   Ann Rheum Dis. 2010;69(1):20-28. doi:10.1136/ard.2008.101766PubMedGoogle ScholarCrossref
3.
Colson  P , Rolain  JM , Raoult  D .  Chloroquine for the 2019 novel coronavirus SARS-CoV-2.   Int J Antimicrob Agents. 2020;55(3):105923. doi:10.1016/j.ijantimicag.2020.105923PubMedGoogle Scholar
4.
Gautret  P , Lagier  JC , Parola  P ,  et al.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.   Int J Antimicrob Agents. 2020;105949. doi:10.1016/j.ijantimicag.2020.105949PubMedGoogle Scholar
5.
Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia.  [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].   Zhonghua Jie He He Hu Xi Za Zhao. 2020;43(0):E019.PubMedGoogle Scholar
6.
Gao  J , Tian  Z , Yang  X .  Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.   Biosci Trends. 2020;14(1):72-73. doi:10.5582/bst.2020.01047PubMedGoogle ScholarCrossref
7.
Canadian Hydroxychloroquine Study Group.  A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.   N Engl J Med. 1991;324(3):150-154. doi:10.1056/NEJM199101173240303PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close